The purpose of this toolkit is to assist Canadian organizations working with international partners to effectively engage in their work. An evaluation report of the NPT communications project has already been prepared; this toolkit focuses primarily on the partnership model rather than the content of the workshops.
The Interagency Coalition on AIDS and Development (ICAD), the Canadian AIDS Society (CAS), CATIE and the Canadian Public Health Association (CPHA) were pleased to offer a webinar series on “New HIV prevention technologies and their implications for HIV prevention in Canada.” Please see below for further information on these webinars:
Webinar 1: New HIV Prevention Technologies (NPTs) – The basics and the state of research
12 July 2011
If you’re wondering what all the buzz is around new HIV prevention technologies, you’re not alone. Recent research advances have reinvigorated the field, with new findings around medical male circumcision, vaccines, microbicides and ARV-based prevention strategies.
As the results of new HIV prevention technology (NPT) trials are released and discussions emerge about the implications of the results, it is important that a range of stakeholders understand what the results mean, and the process that led to their discovery. Understanding the research process will help advocates, policy makers and service providers to prepare for the outcomes of prevention trials and communicate about trial results. This fact sheet outlines the basic steps in the research process and the roll‐out of NPTs; where research is taking place and why; the role and experience of study volunteers; and the roles of other players in NPT research.
This report provides an overview of the proceedings of the ancillary event called: “Prevention technologies in the broader spectrum of HIV prevention” delivered in conjunction with the 2010 Annual Canadian Conference on HIV/AIDS Research in Saskatoon (May 13, 2010). The event was supported by a grant from the Canadian HIV Vaccines Initiative (CHVI). The report also summarizes the process and outcome evaluation findings from the perspective of the 35 participants and the three host organizations: the Canadian AIDS Society (CAS), CATIE and the Interagency Coalition on AIDS and Development (ICAD).
Research and clinical trials of new HIV prevention technologies, such as vaccines, microbicides and pre-exposure prophylaxis, provide hope for more effective prevention of HIV transmission. Communities are aware of research developments and need timely, accurate information which they can use to inform and engage their members. In response to this need, the Canadian AIDS Society, the Canadian AIDS Treatment Information Exchange and the Interagency Coalition on AIDS and Development, in partnership with the Coalition des organismes Québécois de lutte contre le sida, hosted a one-day meeting in Montreal on March 4, 2010 with 74 registered participants from a variety of communities. International and Canadian presenters provided updates on research, ethics … Read more →
There are a number of global efforts underway to develop new technologies to prevent HIV. Currently, there is research being conducted on vaginal and rectal microbicides, vaccines, pre‐exposure prophylaxis (PrEP) and HIV treatment as prevention. This fact sheet provides a brief definition of each of the potential prevention tools being researched, and gives an overview of the current state of research. The fact sheet then provides an overview of the prevention technologies that we currently have at our disposal―female and male condoms, and medical male circumcision―and summarizes recent findings about these technologies. The fact sheet then outlines research into prevention technologies that have had unsuccessful results―diaphragms and cervical barriers, and … Read more →
PrEP could prove to be an important opportunity in the field of HIV prevention, yet there are many ethical and practical concerns that need to be addressed as the research moves forward. Currently, there is limited dialogue around these issues and the impact that PrEP trial results will have in Canada and globally. It is important that Canadians develop an understanding of PrEP and related issues so that they are able to participate in a global dialogue and assess if or how PrEP could benefit Canadians. This fact sheet provides an overview of PrEP research and raises some of the concerns and unanswered questions that require discussion among a broad … Read more →
On November 20, 2010, ICAD held a workshop on PrEP as a potential HIV prevention method. The workshop included presentations from individuals engaged in PrEP trials in Peru and Kenya. The workshop provided Canadian civil society, researchers and government representatives with an opportunity to learn about and discuss PrEP, its potential impact on Canadians, and the role Canadians can play in the international dialogue on PrEP.
PrEP: What is it? What does it mean for Canadians? – Marc-André LeBlanc
Canadian involvement in PrEP work – Madzouka Kokolo
iPrEx: Chemoprophylaxis for HIV Prevention in Men – Pedro Goicochea
HIV Pre‐Exposure Prophylaxis (PrEP) among Discordant Couples: Roll‐out issues , Kenya … Read more →
ICAD/CAS Symposium at Canadian Association of Researchers conference:
Microbicides within the context of comprehensive prevention , Marc-André LeBlanc, Global Campaign for Microbicides (GCM)
State of microbicides research , Susan Schader, McGill University
The Canadian Microbicides Action Plan (CMAP): Overview , San Patten, San Patten and Associates
Engaging communities in Africa in clinical trials , Katie West Slevin, GCM
Emerging Prevention Technologies December 22, 2016 A comprehensive approach to HIV prevention balances structural changes (such as poverty reduction and gender equality), the expansion and strengthening of existing and emerging prevention strategies (such as behavioural interventions,…